SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pharmaids Pharmaceuticals informs about outcome of board meeting

01 Jul 2026 Evaluate

Pursuant Regulation 30 read with Schedule III of Listing Regulations, Pharmaids Pharmaceuticals has informed that the Board of Directors of the Company at their meeting held on Tuesday, June 30, 2026, have, basis recommendation of the Audit Committee, considered and approved the appointment of V Mahendra & Associates Chartered Accountants (FRN: 025356S) as Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27. The disclosure as required under Regulation 30 of the Listing Regulations read with SEBI Master Circular dated January 30, 2026, is enclosed as Annexure A. The above Information is being made available on the Company’s website: www.pharmaids.com.

The above information is a part of company’s filings submitted to BSE.


Pharmaids Pharma Share Price

37.25 -1.72 (-4.41%)
01-Jul-2026 13:17 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1872.00
Dr. Reddys Labs. 1344.25
Cipla 1457.20
Zydus Lifesciences 1109.45
Lupin 2399.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: